Prevalence and Impact of Preexisting Comorbidities on Overall Clinical Outcomes of Hospitalized COVID-19 Patients

Table 4

Overall survival and length of hospital stay in hospitalized COVID-19 patients with or without single and multiple comorbidities. Length of hospital stay data is represented as .

Variable	Total ()	Survivors (, % within total)	Nonsurvivors (, % within total)	Odds ratio (95% CI)	value	Length of hospital stay (in days)	95% CI	value
No comorbidity	151	137 (90.7)	14 (9.3)		≤0.001		5.55-7.40
DM	44	38 (86.4)	6 (13.6)	1.54 (0.55-4.29)	0.404		7.81-11.10	0.006
HTN	30	23 (76.7)	7 (23.3)	2.97 (1.08-8.17)	0.034		6.58-11.42	0.044
CAD	7	4 (57.1)	3 (42.9)	7.33 (1.49-36.16)	0.014		1.34-11.23	0.937
CKD	3	1 (33.3)	2 (66.7)	19.57 (1.66-229.6)	0.018		-0.50-13.84	0.959
	67	46 (68.7)	21 (31.3)	4.46 (2.10-9.49)	≤0.001		7.77-10.65	0.003
	29	16 (55.2)	13 (44.8)	7.95 (3.18-19.86)	≤0.001		6.21-11.79	0.032
	11	6 (54.5)	5 (45.5)	8.15 (2.20-30.16)	0.002		7.61-21.39	≤0.001
	11	2 (18.2)	9 (81.8)	44.03 (8.64-224.27)	≤0.001		5.08-20.38	0.001
	4	3 (75.0)	1 (25.0)	3.26 (0.31-33.49)	0.320		5.32-14.68	0.267
	9	6 (66.7)	3 (33.3)	4.89 (1.10-21.73)	0.037		1.74-10.48	0.865

Note: no comorbidity is the reference group.